Andreas J. Gescher

19.1k total citations · 6 hit papers
166 papers, 15.7k citations indexed

About

Andreas J. Gescher is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Andreas J. Gescher has authored 166 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Molecular Biology, 41 papers in Oncology and 28 papers in Pathology and Forensic Medicine. Recurrent topics in Andreas J. Gescher's work include Genomics, phytochemicals, and oxidative stress (25 papers), Phytochemicals and Antioxidant Activities (24 papers) and Curcumin's Biomedical Applications (22 papers). Andreas J. Gescher is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (25 papers), Phytochemicals and Antioxidant Activities (24 papers) and Curcumin's Biomedical Applications (22 papers). Andreas J. Gescher collaborates with scholars based in United Kingdom, United States and Italy. Andreas J. Gescher's co-authors include William P. Steward, Ricky A. Sharma, Karen Brown, Richard D. Verschoyle, Timothy H. Marczylo, Donald J. L. Jones, Margaret M. Manson, Ketan Patel, Victoria Brown and Darren N. Cooke and has published in prestigious journals such as Cancer Research, Oncogene and Journal of Agricultural and Food Chemistry.

In The Last Decade

Andreas J. Gescher

165 papers receiving 15.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Curcumin: The story so far

2005 1.4k citations Ricky A. Sharma, Andreas J. Gescher et al. European Journal of Cancer profile →
Phase I Clinical Trial of Oral Curcumin

2004 1.0k citations Ricky A. Sharma, Bruno Morgan et al. profile →
Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer.

2001 702 citations Ricky A. Sharma, Margaret M. Manson et al. PubMed profile →
Phase I Dose Escalation Pharmacokinetic Study in Healthy Volunteers of Resveratrol, a Potential Cancer Chemopreventive Agent

2007 675 citations Ketan Patel, Andreas J. Gescher et al. profile →
Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis

2010 550 citations Ketan Patel, Karen Brown et al. profile →
Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.

2001 506 citations Donald J. L. Jones, Richard D. Verschoyle et al. PubMed profile →

Peers

Andreas J. Gescher

BIOCH

PHARM

William P. Steward United Kingdom

Shishir Shishodia United States

Min‐Hsiung Pan Taiwan

Young‐Joon Surh South Korea

Anupam Bishayee United States

Ajaikumar B. Kunnumakkara India

Bokyung Sung United States

Jen‐Kun Lin Taiwan

Ah‐Ng Tony Kong United States

Kwang Seok Ahn South Korea

William P. Steward United Kingdom

Andreas J. Gescher

7.4k ×1.0

5.0k ×0.9

1.9k ×0.8

1.7k ×0.8

BIOCH

1.8k ×0.9

PHARM

Citations per year, relative to Andreas J. Gescher Andreas J. Gescher (= 1×) peers William P. Steward

Countries citing papers authored by Andreas J. Gescher

Since Specialization

Citations

This map shows the geographic impact of Andreas J. Gescher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas J. Gescher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas J. Gescher more than expected).

Fields of papers citing papers by Andreas J. Gescher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas J. Gescher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas J. Gescher. The network helps show where Andreas J. Gescher may publish in the future.

Co-authorship network of co-authors of Andreas J. Gescher

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas J. Gescher. A scholar is included among the top collaborators of Andreas J. Gescher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas J. Gescher. Andreas J. Gescher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Howells, Lynne, Chinenye Iwuji, Shaun Barber, et al.. (2019). Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial. Journal of Nutrition. 149(7). 1133–1139. 181 indexed citations

Teichert, Friederike, Richard D. Verschoyle, Peter Greaves, et al.. (2010). Plasma metabolic profiling reveals age-dependency of systemic effects of green tea polyphenols in mice with and without prostate cancer. Molecular BioSystems. 6(10). 1911–1916. 3 indexed citations

Thomasset, Sarah, David P. Berry, Hong Cai, et al.. (2009). Pilot Study of Oral Anthocyanins for Colorectal Cancer Chemoprevention. Cancer Prevention Research. 2(7). 625–633. 90 indexed citations

Scott, Edwina N., Andreas J. Gescher, William P. Steward, & Karen Brown. (2009). Development of Dietary Phytochemical Chemopreventive Agents: Biomarkers and Choice of Dose for Early Clinical Trials. Cancer Prevention Research. 2(6). 525–530. 58 indexed citations

Verschoyle, Richard D., Peter Greaves, Ketan Patel, et al.. (2008). Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: Relationship with silibinin levels. European Journal of Cancer. 44(6). 898–906. 37 indexed citations

D’Incalci, Maurizio, William P. Steward, & Andreas J. Gescher. (2007). Modulation of response to cancer chemotherapeutic agents by diet constituents – Is the available evidence sufficiently robust for rational advice for patients?. Cancer Treatment Reviews. 33(3). 223–229. 10 indexed citations

Verschoyle, Richard D., Peter Greaves, Hong Cai, et al.. (2007). Evaluation of the cancer chemopreventive efficacy of rice bran in genetic mouse models of breast, prostate and intestinal carcinogenesis. British Journal of Cancer. 96(2). 248–254. 58 indexed citations

Brenner, Dean E. & Andreas J. Gescher. (2005). Cancer chemoprevention: lessons learned and future directions. British Journal of Cancer. 93(7). 735–739. 20 indexed citations

Sharma, Ricky A., Andreas J. Gescher, & William P. Steward. (2005). Curcumin: The story so far. European Journal of Cancer. 41(13). 1955–1968. 1400 indexed citations breakdown →

10.

D’Incalci, Maurizio, William P. Steward, & Andreas J. Gescher. (2005). Use of cancer chemopreventive phytochemicals as antineoplastic agents. The Lancet Oncology. 6(11). 899–904. 85 indexed citations

11.

Cai, Hong, E A Hudson, Richard D. Verschoyle, et al.. (2004). Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo. British Journal of Cancer. 91(7). 1364–1371. 81 indexed citations

12.

Steward, W P, et al.. (2002). Resveratrol—A prostate cancer chemopreventive agent?. Urologic Oncology Seminars and Original Investigations. 7(6). 223–227. 34 indexed citations

13.

Hudson, E A, et al.. (2001). Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. British Journal of Cancer. 85(4). 618–624. 60 indexed citations

14.

Manson, Margaret M., Andreas J. Gescher, E A Hudson, et al.. (2000). Blocking and suppressing mechanisms of chemoprevention by dietary constituents. Toxicology Letters. 112-113. 499–505. 78 indexed citations

15.

Akiyama, Tadakazu, Makiko Shimizu, Tatsuya Tamaoki, et al.. (1999). Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine).. PubMed. 59(17). 4406–12. 30 indexed citations

16.

Courage, C, et al.. (1997). Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine. International Journal of Cancer. 73(5). 763–768. 19 indexed citations

17.

Budworth, Joanna & Andreas J. Gescher. (1995). Differential inhibition of cytosolic and membrane‐derived protein kinase C activity by staurosporine and other kinase inhibitors. FEBS Letters. 362(2). 139–142. 42 indexed citations

18.

Kohl, Christopher, et al.. (1995). Metabolism of the genotoxicant 2-nitropropane to a nitric oxide species. Chemico-Biological Interactions. 97(2). 175–184. 23 indexed citations

19.

Laughton, Charles A., Tracey D. Bradshaw, & Andreas J. Gescher. (1989). Sterically hindered analogues of diacylglycerols. synthesis, binding to the phorbol ester receptor and metabolism in a549 human lung carcinoma cells. International Journal of Cancer. 44(2). 320–324. 4 indexed citations

20.

Gibson, Neil W., et al.. (1981). A comparative study of the anti-tumour activity of N-methylformamide and related compounds.. British Journal of Cancer. 44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact